The CVProfilor® MD-3000 is designed for
physicians outside of the United States.
The CVProfilor® MD-3000 functions similarly to the U.S.
The CVProfilor® MD-3000 model is not cleared by the Food and
Drug Administration (FDA) for marketing in the United States
(please refer to the CVProfilor® DO-2020 for sale in the
The CVProfilor MD-3000 provides a sensitive and specific
guide to the presence of blood vessel disease. The ability
to detect reduced arterial elasticity is a significant
medical advance. The MD-3000 provides physicians with a
simple non-invasive technique for:
Screening patients with risk factors for the early detection
of atherosclerotic disease.
Clinically evaluating the efficacy of prescribed lifestyle
modifications and/or medications.
Monitoring the treatment of patients with hypertension and
other cardiovascular diseases.
Identifying patients with abnormal arterial-wall function
indicative of endothelial dysfunction, and targeting those
patients in need of aggressive medical intervention.